Invention Grant
- Patent Title: 3-dimensional representations of post-contrast enhanced brain lesions
-
Application No.: US16976028Application Date: 2019-02-26
-
Publication No.: US11885861B2Publication Date: 2024-01-30
- Inventor: Darin Okuda
- Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Applicant Address: US TX Austin
- Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
- Current Assignee Address: US TX Austin
- Agency: Norton Rose Fulbright US LLP
- International Application: PCT/US2019/019652 2019.02.26
- International Announcement: WO2019/165464A 2019.08.29
- Date entered country: 2020-08-26
- Main IPC: G01R33/56
- IPC: G01R33/56 ; G06T7/11 ; G06N20/00 ; G01R33/48

Abstract:
3D MRI images of the brain may be created and acquired. After administration of contrast, brain lesions and other abnormalities may be identified and isolated from the 3D MRI images, with each lesion serving as a region of interest (ROI). 3D region of contrast enhancement images may be created from segmented 3D MRI images and different regions of contrast enhancement of the brain lesion may be depicted. Saved regions of contrast enhancement may be converted into stereolithography format, maximum intensity projection (MIP) images, and/or orthographic projection images. Data corresponding to these resulting 3D region of contrast enhancement images may be used to create 3D printed models of the isolated region of contrast enhancement. Analysis of the 3D brain region of contrast enhancement images and the 3D printed region of contrast enhancement models may enable a more efficient and accurate way of determining brain lesion risk factors and effective treatment regimens.
Public/Granted literature
- US20210041518A1 3-DIMENSIONAL REPRESENTATIONS OF POST-CONTRAST ENHANCED BRAIN LESIONS Public/Granted day:2021-02-11
Information query